Alzheimer s Early Detection with FDA Approved Amyvid Inside E Street
Alzheimer's Early Detection with FDA Approved Amyvid - Inside E Street
But recently, the U.S. Food and Drug Administration approved that may help doctors detect signs of the disease in the brain of live patients. The drug allows researchers to use imaging scans to detect amyloid plaque, the brain protein that is thought to be the telltale sign of the disease. Michael Weiner, M.D., heads up the (ADNI), which is currently conducting the largest clinical research study of Alzheimer's in the United States. With the help of Amyvid, his team's research could help diagnose Alzheimer's years before symptoms are displayed. Despite more than 1,000 volunteers, including Weiner himself, by seeking new patients, both those with Alzheimer's and, especially, those with mild cognitive impairment.
Also of interest:
— Receive access to exclusive information, benefits and discounts. Cancel You are leaving AARP.org and going to the website of our trusted provider. The provider’s terms, conditions and policies apply. Please return to AARP.org to learn more about other benefits. Your email address is now confirmed. You'll start receiving the latest news, benefits, events, and programs related to AARP's mission to empower people to choose how they live as they age. You can also by updating your account at anytime. You will be asked to register or log in. Cancel Offer Details Disclosures
Early Detection of Alzheimer' s
Drug may detect Alzheimer' s before symptoms appear
Until recently, the only way to definitively — America's sixth-leading cause of death — was through an autopsy.But recently, the U.S. Food and Drug Administration approved that may help doctors detect signs of the disease in the brain of live patients. The drug allows researchers to use imaging scans to detect amyloid plaque, the brain protein that is thought to be the telltale sign of the disease. Michael Weiner, M.D., heads up the (ADNI), which is currently conducting the largest clinical research study of Alzheimer's in the United States. With the help of Amyvid, his team's research could help diagnose Alzheimer's years before symptoms are displayed. Despite more than 1,000 volunteers, including Weiner himself, by seeking new patients, both those with Alzheimer's and, especially, those with mild cognitive impairment.
Also of interest:
Related
— Receive access to exclusive information, benefits and discounts. Cancel You are leaving AARP.org and going to the website of our trusted provider. The provider’s terms, conditions and policies apply. Please return to AARP.org to learn more about other benefits. Your email address is now confirmed. You'll start receiving the latest news, benefits, events, and programs related to AARP's mission to empower people to choose how they live as they age. You can also by updating your account at anytime. You will be asked to register or log in. Cancel Offer Details Disclosures